Gérard Soula, President and CEO of Adocia, interviewed by Véronique Guisquet during the French Shareholder’s Event Actionaria 2018 – “Face of the leaders”. This year, 23923 visitors went to the Palais des Congrès in Paris (France) for two business investment days: 22 and 23 November 2018. Dear visitors, it was a pleasure to meet you on
Dear Shareholders, Thanks for these quality exchanges during this first day. See you tomorrow at the Palais des congrès; two appointments await you with Adocia: 10:15 – 11:15: meeting of Dr. Gérard Soula, Valérie Danaguézian, Dr. Rémi Soula, Dr. Savita Bernal then 12:00: Dr. Gérard Soula, Adocia CEO interview during “Face aux dirigeants”.   Adocia
Steve Daly, Adocia US General Manager, will be attending the 16th Annual World Congress Insulin Resistance Diabetes & Cardiovascular Disease in Los Angeles next November 29th until December 1st. The Congress is the premiere global meeting dedicated to diabetes, obesity, lipids, cardiovascular disease (CVD), and energy balance, linking basic research to clinical practice, and highlighting
Actionaria: the Event dedicated to Shareholders ! This year, the 21st edition of Actionaria will take place Thursday, November 22, 2018: 1:00 pm – 8:30 pm(last entry at 20h) Friday, November 23, 2018: 9:30 am – 7:00 pm Location: Palais des Congrès de Paris 2 place de la Porte Maillot 75017 Paris – France http://www.actionaria.com/
Diabetes concerns every family About Diabetes and World Diabetes Day Diabetes is a global pandemic, affecting more than 425 million people worldwide in 2017, according to the International Diabetes Federation (IDF). The IDF predicts that this figure will reach 629 million in 2045. The seriousness of the pandemic prompted the United Nations to declare November
The Annual Peptide Therapeutics Symposium, 25 – 26 October 2018 This event held every year in San Diego, California, is a unique forum which brings together world leaders from academia, the biopharmaceutical industry, CMOs, CROs, and investors interested in all aspects of peptide R&D, including drug discovery, safety and toxicology, clinical development, manufacturing, pharmaceutical development,
As usually, Adocia team is attending CPhI, the world’s largest pharmaceutical event. Occasion to network opportunities and cost-effective supplier sourcing. This year the CPhI is hosting over 45,000 pharmaceutical industry professionals from 150+ countries. https://www.cphi.com/ 
Dr. Savita Bernal will make a presentation and participate in a round table dedicated to: Platform Technologies & Novel Therapeutics Panelto. The 18th Annual Biotech in Europe Forum organised by Sachs Associates is recognized as the leading international stage for those interested in investing and partnering in the biotech and life science industry. http://www.sachsforum.com/bef18-about.html   
The European Association for the Study of Diabetes (EASD) is taking place this year at Berlin, Germany from OCtober 1st until October 5th. The Annual Meeting is one of the largest meetings dedicated to the latest developments and insights in diabetology. The meeting attracts key opinion leaders, company executives, scientists, physicians, researchers, nurses and students interested
Next November 4 – 7, 2018 – Steve Daly (Adocia US General Manager) and Mike Nguyen (Adocia Head of BD, New therapeutic Areas) will be attending the next AAPS congress which be held at the Washington Convention Center, Washington, DC, US. This event showcases products like ADME Applications, ADME Services, Apparel, Automated Bioextraction, Bioanalytical Chemistry,